NCT03634475 - A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

April 30, 2019

Conditions

Non-infectious Uveitis

Interventions

DRUG

PP-001

Drug - no placebo

Trial Locations (9)

University Hospital Vienna, Vienna

University Hospital Leuven, Leuven

Charité Berlin, Berlin

LMU Munich, Munich

University Hospital Muenster, Münster

University Hospital Tuebingen, Tübingen

Rotterdam Eye Hospital, Rotterdam

Bristol Eye Hospital, Bristol

Moorefields Eye Hospital, Moorfields